In 2024, Hanmi Pharm conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Waste Generated | 9,285a | 9,372a | 9,370a | |
Total Waste Recovered | 8,041a | 8,112a | 7,960a | |
Total Hazardous Waste Generated | 6,858a | 7,261a | 7,159a | |
Non-Hazardous Waste Disposed | 392a | 505a | 637a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, Hanmi Pharm generated a total of 9,285metric tonnes of waste.a
Of this amount, 86.6% of Hanmi Pharm's total waste generated was recovered through methods such as recycling, reuse, or composting, while 13.4% was disposed of through landfilling, incineration, or combustion.a
In 2024, Hanmi Pharm reported a total waste generation of 9,285 metric tonnes, of which 86.6% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Hanmi Pharm has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2022, Hanmi Pharm's total waste generation has remained relatively stable with no meaningful fluctuations over time, indicating consistency in waste generation practices.a
Over the same period, Hanmi Pharm's waste recovery rate increased by 1.94%, while holding steady in 2024, suggesting past gains in recovery performance have stabilized.a
Overall, Hanmi Pharm’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2024, Hanmi Pharm generated a total of 9,285 metric tonnes of waste.a
Of this amount, 73.86% of Hanmi Pharm's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.26.09% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2022, Hanmi Pharm's total waste generation has shown no significant variation, indicating consistent waste generation patterns with limited progress on reduction initiatives.a
Over the same period, Hanmi Pharm reduced the hazardousness of its waste by 3.33%, with a further 4.67% decline in 2024, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.a
Overall, Hanmi Pharm's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2024, Hanmi Pharm reported that 6,858 metric tonnes of its total waste output were classified as hazardous. This represents 73.86% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.A majority (87.63%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Hanmi Pharm has established processes to reduce the environmental burden of its most harmful waste streams.a